On the buying side, ARK’s most notable investment was in CRISPR Therapeutics AG (NASDAQ:CRSP), acquiring 188,879 shares with a total dollar value of $10,259,907. This purchase indicates a strong ...

According to daily trade disclosures dated August 22, the ARK Next Generation Internet ETF sold 8,476 shares of Shopify ...

Cathie Wood's Ark Invest is optimistic that Robinhood's latest move to prediction markets will help advance the convergence ...

Cathie Wood, the founder and CEO of ARK Invest, is best known for chasing high-growth opportunities in disruptive ...

Cathie Wood is most known for her bold, tech-first investing. She was an outlier during the 2021 boom as her aggressive bets ...

Cathie Wood, the chief at ARK Investment Management, has offloaded approximately $28 million worth of Palantir Technologies.

このアップデートは、アークが8月19日、ARKKに35万6346株のブリッシュ株を追加した後に発表された。この購入は、ニューヨークでの取引終了時点での株価59.51ドルを基にすると、約2120万ドル（約31億4000万円）相当。今回の購入は、ブリッシ ...

Cathie Wood went from selling $22 million worth of Block stock last week to buying $19.2 million this week - a flip-flop that ...

Cathie Wood, the CEO and chief investment officer of ARK Investment Management, has established a reputation thanks to ...

Lauded tech investor Cathie Wood got in on the latest blockbuster crypto IPO, with Ark Invest buying up millions of shares in ...

Cathie Wood’s ARK Invest buys 356K Bullish (BLSH) shares despite a 32% drop. The stock still trades above its IPO price of $37.

ARK also increased its position in CRISPR Therapeutics AG (NASDAQ: CRSP ), acquiring 176,811 shares worth $10,560,921. This trade aligns with ARK’s high conviction in gene-editing technologies, which ...